Ultrasound Guided Lateral Femoral Cutaneous Block (LFCNB) And Femoral Nerve Block (FNB) For Postoperative Pain Control After Hip Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

210 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-10-31

Study Completion Date

2014-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the combination of lateral femoral cutaneous nerve "single shot" and femoral nerve "single shot" block as effective and safe alternative postoperative analgesic technique after hip replacement surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

PENG and LFCN Block Versus Lumbar Plexus Block for Postoperative Analgesia After Total Hip Arthroplasty

NCT05652075

Post Operative Pain Regional Block

UNKNOWN NA

Analgesic Comparison of PENG/LFCN to FICB for Total Hip Arthroplasty

NCT05477641

Analgesia

UNKNOWN NA

Combined PENG and LFCN Block for Total Hip Arthroplasty

NCT04996290

Anesthesia, Conduction Pain, Postoperative Arthroplasty, Replacement, Hip

COMPLETED NA

PENG Block and Lateral Femoral Cutaneous Nerve Block For Hip Replacement Surgery

NCT06040879

POSTOPERATIVE ANALGESIA

COMPLETED NA

Ultrasound-Guided PENG Block vs Femoral Nerve Block for Analgesia Before Spinal Anesthesia in Hip Fracture Surgery

NCT06989047

Proximal Femur Fracture Hip Fracture Pain Management +1 more

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Clinical evaluation via a prospective, double-blinded, randomized clinical trial, whether ultrasound-guided single femoral block and lateral femoral cutaneous nerve blocks with 20 en 10 cc bupivacaine 0.25% respectively vs. the only ultrasound-guided single femoral block with 20 cc bupivacaine 0.25%, given just prior to elective hip surgery procedure, is effective in reducing acute postoperative pain (VAS scores) and postoperative opiate consumption.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

-Postoperative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Group 1 consented subjects who will receive for their hip surgery procedures general anesthesia (sevoflurane) with single shot femoral and lateral femoral cutaneous nerve blocks under ultrasound guidance, with 20 cc of 0.9% saline solution for the femoral block and 10 cc of 0.9% saline solution for lateral femoral cutaneous block, for a total of 30 ml saline solution 0.9%.

Group Type PLACEBO_COMPARATOR

LFCNB

Intervention Type PROCEDURE

LFCNB - Normal Saline solution 10 cc

FNB

Intervention Type PROCEDURE

FNB - Normal saline solution 10 cc

Group 2

Group 2 consented subjects who will receive for their hip surgery procedures general anesthesia (sevoflurane) with single shot femoral and lateral femoral cutaneous nerve blocks under ultrasound guidance, with 20 cc of 0.25% bupivacaine solution for the femoral block and 10 cc of 0.9% saline solution for lateral femoral cutaneous block, for a total of 20 cc 0.25% bupivacaine solution en 10 cc saline solution 0.9%.

Group Type ACTIVE_COMPARATOR

LFCNB

Intervention Type PROCEDURE

LFCNB - Normal Saline solution 10 cc

FNB

Intervention Type PROCEDURE

FNB - Chirocaine 0.25%, 20 cc

Group 3

Group 3 consented subjects who will receive for their hip surgery procedures general anesthesia (sevoflurane) with single shot femoral and lateral femoral cutaneous nerve blocks under ultrasound guidance, with 20 cc of 0.25% bupivacaine solution for the femoral block and 10 cc of 0.25% bupivacaine solution for lateral femoral cutaneous block, for a total of 30 cc of 0.25% bupivacaine solution.

Group Type ACTIVE_COMPARATOR

LFCNB

Intervention Type PROCEDURE

LFCNB - Chirocaine 0.25%, 20 cc

FNB

Intervention Type PROCEDURE

FNB - Chirocaine 0.25%, 20 cc

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LFCNB

LFCNB - Normal Saline solution 10 cc

Intervention Type PROCEDURE

FNB

FNB - Normal saline solution 10 cc

Intervention Type PROCEDURE

LFCNB

LFCNB - Chirocaine 0.25%, 20 cc

Intervention Type PROCEDURE

FNB

FNB - Chirocaine 0.25%, 20 cc

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary hip arthroplasty with posterolateral approach.

Exclusion Criteria

* Known allergy to levobupivacaine and / or piritramide
* Known neurological disorders or peripheral neuropathies
* Existing drug or alcohol abuse
* Chronic use of pain medication (\> started 3 months ago) not related to the hip suffering
* Coagulopathy (international normalized ratio) \> 1.4
* Thrombocytopenia \<70,000 platelets,
* Dementia
* Pregnancy
* Local infection hip
* Hepatic and / or renal impairment
* BMI\> 45.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No